Company
About us
History
Leaderships
Team
EU grants
Requests for Proposal
Sustainability – ESG
Bussines strategy
Quality policy
Virtual Tour
Investors
Corporate documents
Shareholders and shares
Periodic reports
Current reports
Sustainability reports
Corporate governance at Mabion
Financial data
For Investors
Calendar
Resources
Science Hub
Press releases
News
Events
Media kit
Services
Process Development
Analytics
Drug Substance Manufacturing
Contact
Contact form
Contact for investors
Contact for media
Careers
Science News
Resources
Drug product
Bioprocess Optimization Across Upstream and Downstream Processing
Drug development
,
Drug product
,
Drug substance
,
Manufacturing
Rapid Microbiological Methods in Quality Control of Sterile Drugs
Contamination
,
Drug product
,
Microbiology
The Role of Downstream Development in Ensuring Biologic Product Purity and Quality
Drug product
,
Manufacturing
Aseptic Filling in Modern Pharmaceutical Manufacturing
Drug product
,
Manufacturing
Role of Stable Cell Line in Biopharmaceutical Manufacturing
Drug development
,
Drug product
,
Manufacturing
CHO Cell Lines for Recombinant Protein Production
Drug development
,
Drug product
,
Manufacturing
Leading European CDMO for Drug Product Manufacturing
Drug development
,
Drug product
,
Manufacturing
Qualitative Analysis of Host Cell Proteins using Mass Spectrometry
Analytics
,
Drug development
,
Drug product
,
Drug substance
Impact of immunogenicity on efficacy and safety of biosimilars – importance of ADA and nAb testing during the clinical development
Biologics
,
Drug product